Skip to main content

Table 2 Chi-square analysis for clinicopathologic variables in patients with M1 category GEP-NENs who did or did not undergo surgery

From: Clinicopathologic characteristics and prognosis of gastroenteropancreatic neuroendocrine neoplasms: a multicenter study in South China

Variable

Surgery group [cases (%)]

Non-surgery group [cases (%)]

P value

Total

127

131

 

Gender

  

0.233

 Male

93 (73.2)

87 (66.4)

 

 Female

34 (26.8)

44 (33.6)

 

Age (years)

  

0.403

 ≤50

52 (40.9)

47 (35.9)

 

 >50

75 (59.1)

84 (64.1)

 

Tumor functionality

  

0.144

 Nonfunctional

112 (88.2)

107 (81.7)

 

 Functional

15 (11.8)

24 (18.3)

 

Tumor location

  

<0.001

 Stomach

39 (30.7)

29 (22.1)

 

 Pancreas

33 (26.0)

70 (53.4)

 

 Small intestine

17 (13.4)

8 (6.1)

 

 Appendix

1 (0.8)

0 (0.0)

 

 Colon

10 (7.9)

4 (3.1)

 

 Rectum

27 (21.2)

20 (15.3)

 

Tumor size (cm)

  

0.006

 <2.0

25 (19.7)

14 (10.7)

 

 2.0–4.0

50 (39.4)

38 (29.0)

 

 >4.0

52 (40.9)

79 (60.3)

 

Grade

  

0.743

 G1

25 (19.7)

24 (18.3)

 

 G2

46 (36.2)

43 (32.8)

 

 G3

56 (44.1)

64 (48.9)

 

Tumor type

  

0.574

 NET

70 (55.1)

65 (49.6)

 

 NEC

52 (40.9)

62 (47.3)

 

 MANEC

5 (3.9)

4 (3.1)

 
  1. NET neuroendocrine tumor, NEC neuroendocrine carcinoma, MANEC mixed adenoneuroendocrine carcinoma